Mivazerol

Mivazerol

SCHEMBL8097939

NC(=O)c1cccc(Cc2c[nH]cn2)c1O

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 7/20 0.39
HMGB1 P09429 1/20 0.37
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
HSD17B10 Q99714 1/20 0.34
AURKA O14965 5/20 0.33
CSNK1A1 P48729 2/20 0.33
DYRK1B Q9Y463 2/20 0.33
PLK4 O00444 1/20 0.33
CHEK1 O14757 1/20 0.33
DAPK3 O43293 1/20 0.33
MAP4K4 O95819 1/20 0.33
CSF1R P07333 1/20 0.33
RET P07949 1/20 0.33
FGFR1 P11362 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Mivazerol SCHEMBL593708 1.00 PARP1 (0.39) PARP1HMGB1MEN1KMT2AKDM4E
Mivazerol SCHEMBL8865135 0.99 PARP1 (0.38) PARP1HMGB1MEN1KMT2AKDM4E
SCHEMBL9647479 0.88 P2RX7 (0.39) HMGB1MEN1KMT2AKDM4EALDH1A1
SCHEMBL9518487 0.87 HMGB1 (0.48) HMGB1MEN1KMT2AKDM4EALDH1A1
SCHEMBL4759339 0.87 PARP1 (0.39) PARP1MEN1KMT2AKDM4EALDH1A1
Hydrochloric Acid SCHEMBL10401999 0.86 HMGB1 (0.47) HMGB1MEN1KMT2AKDM4EALDH1A1
SCHEMBL8089240 0.86 HMGB1 (0.31) HMGB1
SCHEMBL9645443 0.85 MPO (0.38) HMGB1KDM4E
SCHEMBL9647526 0.85 PLK1 (0.38) HMGB1KDM4EALDH1A1HPGDHSD17B10
Hydrochloric Acid SCHEMBL10402113 0.84 MPO (0.37) HMGB1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0626372-B1 2-hydroxy-3-[1-(1H-imidazol-4-yl)alkyl]benzenecarboximid-amides for the treatment of glaucoma UCB SA (BE) 2000-12-20 EP claimed
EP-0626372-B1 2-hydroxy-3-[1-(1H-imidazol-4-yl)alkyl]benzenecarboximid-amides for the treatment of glaucoma UCB SA (BE) 2000-12-20 EP disclosed
EP-0626372-A1 2-hydroxy-3- 1-(1H-imidazol-4-yl)alkyl benzenecarboximid-amides for the treatment of glaucoma U C B, S.A. (BE) 1994-11-30 EP disclosed